NSHS — Nanosphere Health Sciences Balance Sheet
0.000.00%
Last trade - 00:00- CA$0.21m
- CA$0.29m
Annual balance sheet for Nanosphere Health Sciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 0.131 | 0.055 | 0.009 | 0.002 | 0.002 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.002 | 0.005 | 0.009 | 0.012 | 0.015 |
| Total Current Assets | 0.133 | 0.06 | 0.018 | 0.014 | 0.017 |
| Long Term Investments | |||||
| Total Assets | 0.133 | 0.06 | 0.018 | 0.014 | 0.017 |
| Payable / Accrued | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Current Liabilities | 1.21 | 1.37 | 1.57 | 1.23 | 1.37 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 1.21 | 1.37 | 1.57 | 1.23 | 1.37 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -1.08 | -1.31 | -1.56 | -1.22 | -1.35 |
| Total Liabilities & Shareholders' Equity | 0.133 | 0.06 | 0.018 | 0.014 | 0.017 |
| Total Common Shares Outstanding |